Search research articles
Contact Us
Filters
Showing results (151-160 of 193) with videos related to
Page
of 20
Sort By:
Oncogene
|
November 7, 2025
Clinical implications of whole genome sequencing in metastatic colorectal cancer
Lidwien P Smabers, Hilde H Nienhuis, Wendy W J de Leng, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 28, 2024
Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response
Lidwien P Smabers, Emerens Wensink, Carla S Verissimo, et al.
Frontiers in Oncology
|
September 23, 2022
Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study
Niek A Peters, Alexander Constantinides, Inge Ubink, et al.
JAMA Oncology
|
November 25, 2020
Perceived Care and Well-being of Patients With Cancer and Matched Norm Participants in the COVID-19 Crisis: Results of a Survey of Participants in the Dutch PROFILES Registry
Lonneke V van de Poll-Franse, Belle H de Rooij, Nicole J E Horevoorts, et al.
Medicine and Science in Sports and Exercise
|
December 24, 2015
Effects of an Exercise Program in Colon Cancer Patients undergoing Chemotherapy
Jonna K Van Vulpen, Miranda J Velthuis, Charlotte N Steins Bisschop, et al.
Nature Communications
|
November 15, 2014
Genomic landscape of metastatic colorectal cancer
Josien C Haan, Mariette Labots, Christian Rausch, et al.
Journal of the National Cancer Institute
|
June 1, 2021
Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer
Jun Yin, Romain Cohen, Zhaohui Jin, et al.
The New England Journal of Medicine
|
February 7, 2009
Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer
Jolien Tol, Miriam Koopman, Annemieke Cats, et al.
Cancer Medicine
|
December 19, 2019
Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial
Sophie A Kurk, Petra H M Peeters, Bram Dorresteijn, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 7, 2025
Chronological survival improvement over time with oxaliplatin-based chemotherapy plus targeted agents in metastatic colorectal cancer: An ARCAD database study
Kazumasa Yamamoto, Hideaki Bando, Toshihiro Misumi, et al.
Page
of 20
Search research articles
Search
Showing results (151-160 of 193) with videos related to
Sort By:
Page
of 20
Oncogene
|
November 7, 2025
Clinical implications of whole genome sequencing in metastatic colorectal cancer
Lidwien P Smabers, Hilde H Nienhuis, Wendy W J de Leng, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 28, 2024
Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response
Lidwien P Smabers, Emerens Wensink, Carla S Verissimo, et al.
Frontiers in Oncology
|
September 23, 2022
Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study
Niek A Peters, Alexander Constantinides, Inge Ubink, et al.
JAMA Oncology
|
November 25, 2020
Perceived Care and Well-being of Patients With Cancer and Matched Norm Participants in the COVID-19 Crisis: Results of a Survey of Participants in the Dutch PROFILES Registry
Lonneke V van de Poll-Franse, Belle H de Rooij, Nicole J E Horevoorts, et al.
Medicine and Science in Sports and Exercise
|
December 24, 2015
Effects of an Exercise Program in Colon Cancer Patients undergoing Chemotherapy
Jonna K Van Vulpen, Miranda J Velthuis, Charlotte N Steins Bisschop, et al.
Nature Communications
|
November 15, 2014
Genomic landscape of metastatic colorectal cancer
Josien C Haan, Mariette Labots, Christian Rausch, et al.
Journal of the National Cancer Institute
|
June 1, 2021
Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer
Jun Yin, Romain Cohen, Zhaohui Jin, et al.
The New England Journal of Medicine
|
February 7, 2009
Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer
Jolien Tol, Miriam Koopman, Annemieke Cats, et al.
Cancer Medicine
|
December 19, 2019
Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial
Sophie A Kurk, Petra H M Peeters, Bram Dorresteijn, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 7, 2025
Chronological survival improvement over time with oxaliplatin-based chemotherapy plus targeted agents in metastatic colorectal cancer: An ARCAD database study
Kazumasa Yamamoto, Hideaki Bando, Toshihiro Misumi, et al.
Page
of 20